• Address unmet medical needs in infectious diseases and cancer, using innovative therapeutic protein variants identified from a proprietary and original use of natural human genetic variability More
The Pierre Fabre Group, the second-largest independent laboratory in France, employs about 9,300 people and achieved sales of 1.47 billion euros in 2004. More
An innovative company engaged in the development and commercialisation of its proprietary Gene Transport Unit (GTU®) technology, with applications in DNA vaccination and immuno- and gene therapies More